Gastric cancer (HER2-positive metastatic) - trastuzumab: consultee and commentator comments on the ACD
Gastric cancer (HER2-positive metastatic) - trastuzumab: Cancer Research UK response
Gastric cancer (HER2-positive metastatic) - trastuzumab: Centre for Reviews and Dissemination - ERG response
Gastric cancer (HER2-positive metastatic) - trastuzumab: Roche response
Gastric cancer (HER2-positive metastatic) - trastuzumab: Royal College of Nursing response
Gastric cancer (HER2-positive metastatic) - trastuzumab: Royal College of Physicians/NCRI/RCR/ACP/JCCO response
Gastric cancer (HER2-positive metastatic) - trastuzumab: Welsh Assembly Government response
This page was last updated: 23 September 2010